Amrutanjan Health Care Share Price
512.65+0.00 (-0.85%)
-26.34% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
LAURUSLABSNSE
ZYDUSLIFENSE
DRREDDYNSE
CIPLANSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
AMRUTANJANNSE
Amrutanjan Health Care Share Price
512.65+0.00 (-0.85%)
-26.34% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| 11% | 9% | 10% | 11% |
| 10% | -1% | 13% | 14% |
| 7% | -11% | -6% | -26% |
| 19% | 18% | 16% | 17% |
Peer Comparison
Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
LAURUSLABS
ZYDUSLIFE
DRREDDY
CIPLA
MANKIND
AUROPHARMA
LUPIN
AMRUTANJAN
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,908.7 | ₹456593 Cr | 41.64 | 8.29 | 58.23 | ₹11479 Cr |
| 11,120.5 | ₹296741 Cr | 88.24 | 42.53 | 146.01 | ₹2568 Cr |
| 4,626.2 | ₹175578 Cr | 82.66 | 14.04 | 106.21 | ₹2163 Cr |
| 2,304.4 | ₹124380 Cr | 92.83 | 8.17 | 33.94 | ₹889 Cr |
| 1,235 | ₹119700 Cr | 28.64 | 9.27 | 62.23 | ₹5040 Cr |
| 1,396.5 | ₹116771 Cr | 41.71 | 11.08 | 59.16 | ₹4196 Cr |
| 1,421.8 | ₹114397 Cr | 39.49 | 10.86 | 52.6 | ₹3879 Cr |
| 2,636.7 | ₹108641 Cr | 48.44 | 17.23 | 76.25 | ₹1913 Cr |
| 1,803.3 | ₹103971 Cr | 26.06 | 19.57 | 103.44 | ₹3505 Cr |
| 2,002.6 | ₹91413 Cr | 17.56 | 25.26 | 150.99 | ₹5333 Cr |
| 514.35 | ₹1495 Cr | 26.09 | 5.98 | 22.8 | ₹58 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 | Dec 2019 | Sep 2019 | Jun 2019 | Mar 2019 | Dec 2018 | Sep 2018 | Jun 2018 | Mar 2018 | Dec 2017 | Sep 2017 | Jun 2017 | Mar 2017 | Dec 2016 | Sep 2016 | Jun 2016 | Mar 2016 | Dec 2015 | Sep 2015 | Jun 2015 | Mar 2015 | Dec 2014 | Sep 2014 | Jun 2014 | Mar 2014 | Dec 2013 | Sep 2013 | Jun 2013 | Mar 2013 | Dec 2012 | Sep 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹135 Cr | ₹103 Cr | ₹150 Cr | ₹141 Cr | ₹118 Cr | ₹94 Cr | ₹135 Cr | ₹123 Cr | ₹110 Cr | ₹84 Cr | ₹127 Cr | ₹117 Cr | ₹99 Cr | ₹78 Cr | ₹100 Cr | ₹98 Cr | ₹111 Cr | ₹71 Cr | ₹107 Cr | ₹111 Cr | ₹110 Cr | ₹78 Cr | ₹94 Cr | ₹100 Cr | ₹92 Cr | ₹47 Cr | ₹59 Cr | ₹83 Cr | ₹75 Cr | ₹45 Cr | ₹86 Cr | ₹70 Cr | ₹62 Cr | ₹36 Cr | ₹73 Cr | ₹63 Cr | ₹56 Cr | ₹32 Cr | ₹70 Cr | ₹59 Cr | ₹56 Cr | ₹34 Cr | ₹59 Cr | ₹54 Cr | ₹45 Cr | ₹29 Cr | ₹49 Cr | ₹48 Cr | ₹41 Cr | ₹26 Cr | ₹42 Cr | ₹41 Cr | ₹33 Cr | ₹22 Cr | ₹44 Cr | ₹39 Cr | ₹32 Cr |
| ₹3 Cr | ₹4 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹5 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹5 Cr | ₹3 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹4 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹57 L | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹93 L | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹97 L | ₹1 Cr | ₹94 L | ₹37 L | ₹82 L | ₹90 L | ₹75 L | ₹1 Cr | ₹97 L | ₹1 Cr |
| ₹138 Cr | ₹107 Cr | ₹154 Cr | ₹145 Cr | ₹122 Cr | ₹98 Cr | ₹140 Cr | ₹127 Cr | ₹114 Cr | ₹88 Cr | ₹132 Cr | ₹121 Cr | ₹103 Cr | ₹82 Cr | ₹105 Cr | ₹101 Cr | ₹114 Cr | ₹74 Cr | ₹112 Cr | ₹114 Cr | ₹115 Cr | ₹81 Cr | ₹97 Cr | ₹103 Cr | ₹96 Cr | ₹49 Cr | ₹62 Cr | ₹85 Cr | ₹77 Cr | ₹46 Cr | ₹89 Cr | ₹72 Cr | ₹64 Cr | ₹37 Cr | ₹74 Cr | ₹65 Cr | ₹58 Cr | ₹33 Cr | ₹70 Cr | ₹60 Cr | ₹57 Cr | ₹35 Cr | ₹61 Cr | ₹55 Cr | ₹47 Cr | ₹30 Cr | ₹50 Cr | ₹49 Cr | ₹42 Cr | ₹27 Cr | ₹43 Cr | ₹42 Cr | ₹34 Cr | ₹23 Cr | ₹46 Cr | ₹40 Cr | ₹33 Cr |
| ₹115 Cr | ₹99 Cr | ₹126 Cr | ₹117 Cr | ₹103 Cr | ₹87 Cr | ₹119 Cr | ₹101 Cr | ₹98 Cr | ₹82 Cr | ₹112 Cr | ₹97 Cr | ₹94 Cr | ₹72 Cr | ₹89 Cr | ₹87 Cr | ₹96 Cr | ₹69 Cr | ₹91 Cr | ₹86 Cr | ₹88 Cr | ₹65 Cr | ₹83 Cr | ₹74 Cr | ₹65 Cr | ₹40 Cr | ₹51 Cr | ₹72 Cr | ₹64 Cr | ₹47 Cr | ₹68 Cr | ₹64 Cr | ₹54 Cr | ₹39 Cr | ₹63 Cr | ₹57 Cr | ₹43 Cr | ₹34 Cr | ₹63 Cr | ₹51 Cr | ₹46 Cr | ₹32 Cr | ₹51 Cr | ₹43 Cr | ₹36 Cr | ₹28 Cr | ₹41 Cr | ₹39 Cr | ₹35 Cr | ₹26 Cr | ₹33 Cr | ₹34 Cr | ₹30 Cr | ₹22 Cr | ₹35 Cr | ₹35 Cr | ₹29 Cr |
| ₹27 Cr | ₹10 Cr | ₹30 Cr | ₹29 Cr | ₹21 Cr | ₹13 Cr | ₹23 Cr | ₹28 Cr | ₹18 Cr | ₹8 Cr | ₹21 Cr | ₹25 Cr | ₹11 Cr | ₹11 Cr | ₹18 Cr | ₹16 Cr | ₹19 Cr | ₹6 Cr | ₹22 Cr | ₹29 Cr | ₹27 Cr | ₹17 Cr | ₹15 Cr | ₹29 Cr | ₹32 Cr | ₹10 Cr | ₹12 Cr | ₹14 Cr | ₹13 Cr | -₹30,000 | ₹21 Cr | ₹8 Cr | ₹10 Cr | -₹1 Cr | ₹11 Cr | ₹9 Cr | ₹15 Cr | -₹90 L | ₹8 Cr | ₹10 Cr | ₹12 Cr | ₹4 Cr | ₹10 Cr | ₹12 Cr | ₹11 Cr | ₹3 Cr | ₹10 Cr | ₹11 Cr | ₹7 Cr | ₹1 Cr | ₹10 Cr | ₹9 Cr | ₹5 Cr | ₹1 Cr | ₹11 Cr | ₹5 Cr | ₹5 Cr |
| ₹5 L | ₹4 L | ₹5 L | ₹5 L | ₹5 L | ₹5 L | ₹4 L | ₹6 L | ₹6 L | ₹7 L | ₹5 L | ₹5 L | ₹3 L | ₹2 L | ₹2 L | ₹2 L | ₹2 L | ₹2 L | ₹30 L | ₹3 L | ₹7 L | ₹9 L | ₹37 L | ₹4 L | ₹5 L | ₹5 L | ₹7 L | ₹5 L | ₹5 L | ₹5 L | ₹3 L | ₹0 | ₹4 L | ₹2 L | ₹3 L | ₹10,000 | ₹4 L | ₹6 L | ₹7 L | ₹7 L | ₹10 L | ₹6 L | ₹2 L | ₹3 L | ₹4 L | ₹10,000 | ₹4 L | ₹11 L | ₹16 L | ₹17 L | ₹33 L | ₹39 L | ₹45 L | ₹45 L | ₹73 L | ₹57 L | ₹54 L |
| ₹23 Cr | ₹6 Cr | ₹21 Cr | ₹26 Cr | ₹19 Cr | ₹11 Cr | ₹21 Cr | ₹26 Cr | ₹16 Cr | ₹6 Cr | ₹20 Cr | ₹24 Cr | ₹9 Cr | ₹9 Cr | ₹16 Cr | ₹15 Cr | ₹17 Cr | ₹5 Cr | ₹20 Cr | ₹28 Cr | ₹26 Cr | ₹16 Cr | ₹14 Cr | ₹28 Cr | ₹31 Cr | ₹9 Cr | ₹11 Cr | ₹13 Cr | ₹12 Cr | -₹91 L | ₹20 Cr | ₹8 Cr | ₹9 Cr | -₹2 Cr | ₹10 Cr | ₹10 Cr | ₹14 Cr | -₹2 Cr | ₹7 Cr | ₹12 Cr | ₹11 Cr | ₹3 Cr | ₹10 Cr | ₹12 Cr | ₹11 Cr | ₹3 Cr | ₹9 Cr | ₹10 Cr | ₹6 Cr | ₹64 L | ₹9 Cr | ₹8 Cr | ₹4 Cr | ₹13 L | ₹10 Cr | ₹4 Cr | ₹3 Cr |
| ₹17 Cr | ₹4 Cr | ₹16 Cr | ₹19 Cr | ₹14 Cr | ₹8 Cr | ₹15 Cr | ₹19 Cr | ₹12 Cr | ₹5 Cr | ₹14 Cr | ₹17 Cr | ₹7 Cr | ₹7 Cr | ₹13 Cr | ₹11 Cr | ₹13 Cr | ₹4 Cr | ₹15 Cr | ₹21 Cr | ₹20 Cr | ₹12 Cr | ₹10 Cr | ₹21 Cr | ₹24 Cr | ₹6 Cr | ₹8 Cr | ₹9 Cr | ₹8 Cr | -₹70 L | ₹14 Cr | ₹5 Cr | ₹6 Cr | -₹1 Cr | ₹6 Cr | ₹6 Cr | ₹9 Cr | -₹1 Cr | ₹3 Cr | ₹9 Cr | ₹7 Cr | ₹2 Cr | ₹5 Cr | ₹9 Cr | ₹7 Cr | ₹2 Cr | ₹6 Cr | ₹7 Cr | ₹4 Cr | ₹73 L | ₹6 Cr | ₹5 Cr | ₹3 Cr | ₹16 L | ₹7 Cr | ₹2 Cr | ₹2 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | Mar 2009 | Mar 2008 | Mar 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr |
| -₹60 L | ₹42 L | -₹40 L | ₹1 Cr | ₹61 L | ₹62 L | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹368 Cr | ₹323 Cr | ₹286 Cr | ₹287 Cr | ₹262 Cr | ₹212 Cr | ₹157 Cr | ₹143 Cr | ₹126 Cr | ₹113 Cr | ₹118 Cr | ₹102 Cr | ₹94 Cr | ₹85 Cr | ₹78 Cr | ₹100 Cr | ₹94 Cr | ₹91 Cr | ₹22 Cr | ₹20 Cr |
| ₹368 Cr | ₹323 Cr | ₹286 Cr | ₹287 Cr | ₹262 Cr | ₹212 Cr | ₹157 Cr | ₹143 Cr | ₹126 Cr | ₹113 Cr | ₹118 Cr | ₹102 Cr | ₹94 Cr | ₹85 Cr | ₹78 Cr | ₹100 Cr | ₹94 Cr | ₹91 Cr | ₹22 Cr | ₹20 Cr |
| ₹370 Cr | ₹327 Cr | ₹288 Cr | ₹291 Cr | ₹265 Cr | ₹216 Cr | ₹159 Cr | ₹146 Cr | ₹129 Cr | ₹116 Cr | ₹120 Cr | ₹105 Cr | ₹97 Cr | ₹88 Cr | ₹81 Cr | ₹103 Cr | ₹97 Cr | ₹94 Cr | ₹25 Cr | ₹23 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹6 Cr | ₹3 Cr | ₹1 Cr | ₹21 L | ₹6 Cr | ₹8 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹2 Cr | ₹0 |
| -₹5 Cr | -₹3 Cr | -₹3 Cr | -₹4 Cr | -₹4 Cr | -₹3 Cr | -₹4 Cr | -₹4 Cr | -₹4 Cr | -₹3 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹4 Cr | ₹2 Cr |
| ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹57 L | ₹48 L | ₹88 L | ₹1 Cr | ₹28 L | ₹28 L | ₹47 L | ₹42 L | ₹40 L | ₹42 L | ₹46 L | ₹44 L | ₹39 L | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹10 Cr | ₹8 Cr | ₹7 Cr | ₹8 Cr | ₹7 Cr | ₹6 Cr | ₹6 Cr | ₹5 Cr | ₹5 Cr | ₹4 Cr | ₹73 L | ₹60 L | ₹59 L | ₹45 L | ₹20 L | ₹3 L | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹7 Cr | ₹7 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹75 L | ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹9 Cr | ₹8 Cr | ₹4 Cr | ₹3 Cr | ₹12 Cr | ₹10 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹71 Cr | ₹69 Cr | ₹56 Cr | ₹47 Cr | ₹60 Cr | ₹41 Cr | ₹31 Cr | ₹30 Cr | ₹26 Cr | ₹25 Cr | ₹9 Cr | ₹7 Cr | ₹7 Cr | ₹9 Cr | ₹8 Cr | ₹6 Cr | ₹12 Cr | ₹7 Cr | ₹6 Cr | ₹6 Cr |
| ₹40 Cr | ₹12 Cr | ₹10 Cr | ₹10 Cr | ₹13 Cr | ₹8 Cr | ₹6 Cr | ₹4 Cr | ₹3 Cr | ₹4 Cr | ₹14 Cr | ₹10 Cr | ₹7 Cr | ₹9 Cr | ₹7 Cr | ₹10 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹2 Cr | ₹0 | ₹0 | ₹6 Cr | ₹13 Cr | ₹14 Cr | ₹22 Cr | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹16 Cr | ₹4 Cr | ₹4 Cr | ₹5 Cr | ₹4 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹59 L | ₹2 Cr | ₹6 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹5 Cr | ₹1 Cr | ₹97 L |
| ₹126 Cr | ₹85 Cr | ₹70 Cr | ₹63 Cr | ₹77 Cr | ₹52 Cr | ₹39 Cr | ₹36 Cr | ₹32 Cr | ₹32 Cr | ₹25 Cr | ₹23 Cr | ₹24 Cr | ₹35 Cr | ₹34 Cr | ₹43 Cr | ₹18 Cr | ₹14 Cr | ₹10 Cr | ₹8 Cr |
| ₹504 Cr | ₹418 Cr | ₹364 Cr | ₹358 Cr | ₹346 Cr | ₹271 Cr | ₹201 Cr | ₹183 Cr | ₹162 Cr | ₹149 Cr | ₹149 Cr | ₹130 Cr | ₹124 Cr | ₹127 Cr | ₹124 Cr | ₹153 Cr | ₹119 Cr | ₹111 Cr | ₹47 Cr | ₹41 Cr |
| ₹7 Cr | ₹16 Cr | ₹16 Cr | ₹10 Cr | ₹10 Cr | ₹13 Cr | ₹13 Cr | ₹8 Cr | ₹11 Cr | ₹12 Cr | ₹14 Cr | ₹17 Cr | ₹15 Cr | ₹13 Cr | ₹11 Cr | ₹5 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹2 Cr | ₹0 | ₹0 | ₹6 Cr | ₹13 Cr | ₹22 Cr | ₹27 Cr | ₹1 Cr | ₹21 L | ₹8 Cr | ₹8 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹89 Cr | ₹82 Cr | ₹76 Cr | ₹74 Cr | ₹48 Cr | ₹39 Cr | ₹39 Cr | ₹35 Cr | ₹33 Cr | ₹30 Cr | ₹39 Cr | ₹26 Cr | ₹32 Cr | ₹32 Cr | ₹31 Cr | ₹40 Cr | ₹24 Cr | ₹25 Cr | ₹34 Cr | ₹25 Cr |
| ₹38 Cr | ₹32 Cr | ₹26 Cr | ₹25 Cr | ₹19 Cr | ₹16 Cr | ₹13 Cr | ₹9 Cr | ₹6 Cr | ₹3 Cr | ₹16 Cr | ₹13 Cr | ₹18 Cr | ₹15 Cr | ₹12 Cr | ₹10 Cr | ₹9 Cr | ₹9 Cr | ₹14 Cr | ₹13 Cr |
| ₹51 Cr | ₹49 Cr | ₹50 Cr | ₹49 Cr | ₹28 Cr | ₹23 Cr | ₹26 Cr | ₹26 Cr | ₹28 Cr | ₹27 Cr | ₹22 Cr | ₹13 Cr | ₹15 Cr | ₹17 Cr | ₹19 Cr | ₹30 Cr | ₹16 Cr | ₹16 Cr | ₹19 Cr | ₹13 Cr |
| ₹105 Cr | ₹16 Cr | ₹2 Cr | ₹1 Cr | ₹16 Cr | ₹41 L | ₹0 | ₹0 | ₹0 | ₹68 L | ₹72 L | ₹4 Cr | ₹97 L | ₹54 L | ₹35 L | ₹44 L | ₹7 Cr | ₹2 Cr | ₹3 Cr | ₹3 Cr |
| ₹5 L | ₹5 L | ₹4 L | ₹2 L | ₹5 Cr | ₹12 Cr | ₹18 Cr | ₹16 Cr | ₹8 Cr | ₹7 Cr | ₹10 Cr | ₹14 Cr | ₹14 Cr | ₹30 Cr | ₹31 Cr | ₹52 Cr | ₹46 Cr | ₹43 L | ₹43 L | ₹11 L |
| ₹5 L | ₹5 L | ₹4 L | ₹2 L | ₹5 Cr | ₹12 Cr | ₹18 Cr | ₹16 Cr | ₹8 Cr | ₹7 Cr | ₹10 Cr | ₹14 Cr | ₹14 Cr | ₹30 Cr | ₹31 Cr | ₹52 Cr | ₹46 Cr | ₹43 L | ₹43 L | ₹11 L |
| ₹9 Cr | ₹20 Cr | ₹4 Cr | ₹5 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹5 Cr | ₹21 Cr | ₹21 Cr | ₹20 Cr | ₹19 Cr | ₹22 Cr | ₹4 Cr | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹46 Cr | ₹42 Cr | ₹12 Cr | ₹43 Cr | ₹17 Cr | ₹8 Cr | ₹28 Cr | ₹28 L | ₹4 Cr | ₹0 | ₹0 | ₹0 | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹212 Cr | ₹128 Cr | ₹68 Cr | ₹98 Cr | ₹72 Cr | ₹48 Cr | ₹75 Cr | ₹44 Cr | ₹41 Cr | ₹41 Cr | ₹54 Cr | ₹52 Cr | ₹51 Cr | ₹69 Cr | ₹74 Cr | ₹86 Cr | ₹68 Cr | ₹19 Cr | ₹22 Cr | ₹15 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹3 Cr | ₹0 | ₹5,000 | ₹5 Cr | ₹8 Cr | ₹6 Cr | ₹0 | ₹2 Cr | ₹0 | ₹2 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹4 Cr | ₹17 Cr | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹37 Cr | ₹27 Cr | ₹29 Cr | ₹29 Cr | ₹26 Cr | ₹17 Cr | ₹24 Cr | ₹15 Cr | ₹10 Cr | ₹10 Cr | ₹8 Cr | ₹7 Cr | ₹7 Cr | ₹7 Cr | ₹9 Cr | ₹9 Cr | ₹7 Cr | ₹5 Cr | ₹9 Cr | ₹9 Cr |
| ₹61 Cr | ₹56 Cr | ₹48 Cr | ₹33 Cr | ₹38 Cr | ₹18 Cr | ₹26 Cr | ₹33 Cr | ₹28 Cr | ₹29 Cr | ₹26 Cr | ₹26 Cr | ₹24 Cr | ₹27 Cr | ₹13 Cr | ₹12 Cr | ₹10 Cr | ₹13 Cr | ₹8 Cr | ₹5 Cr |
| ₹33 Cr | ₹83 Cr | ₹27 Cr | ₹70 Cr | ₹88 Cr | ₹139 Cr | ₹36 Cr | ₹81 Cr | ₹73 Cr | ₹31 Cr | ₹48 Cr | ₹38 Cr | ₹35 Cr | ₹15 Cr | ₹15 Cr | ₹20 Cr | ₹24 Cr | ₹68 Cr | ₹3 Cr | ₹8 Cr |
| ₹2 Cr | ₹1 Cr | ₹81 L | ₹6 Cr | ₹6 Cr | ₹7 Cr | ₹4 Cr | ₹3 Cr | ₹7 Cr | ₹1 Cr | ₹4 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹80 L | ₹2 L | ₹8 L |
| ₹155 Cr | ₹123 Cr | ₹191 Cr | ₹116 Cr | ₹109 Cr | ₹35 Cr | ₹36 Cr | ₹6 Cr | ₹3 Cr | ₹35 Cr | ₹9 Cr | ₹4 Cr | ₹6 Cr | ₹7 Cr | ₹8 Cr | ₹8 Cr | ₹8 Cr | ₹6 Cr | ₹5 Cr | ₹4 Cr |
| ₹292 Cr | ₹291 Cr | ₹296 Cr | ₹260 Cr | ₹275 Cr | ₹223 Cr | ₹126 Cr | ₹140 Cr | ₹121 Cr | ₹108 Cr | ₹95 Cr | ₹79 Cr | ₹73 Cr | ₹58 Cr | ₹50 Cr | ₹67 Cr | ₹51 Cr | ₹92 Cr | ₹25 Cr | ₹26 Cr |
| ₹165 Cr | ₹206 Cr | ₹226 Cr | ₹197 Cr | ₹197 Cr | ₹171 Cr | ₹87 Cr | ₹104 Cr | ₹89 Cr | ₹76 Cr | ₹69 Cr | ₹56 Cr | ₹49 Cr | ₹22 Cr | ₹16 Cr | ₹24 Cr | ₹33 Cr | ₹79 Cr | ₹16 Cr | ₹18 Cr |
| ₹504 Cr | ₹418 Cr | ₹364 Cr | ₹358 Cr | ₹346 Cr | ₹271 Cr | ₹201 Cr | ₹183 Cr | ₹162 Cr | ₹149 Cr | ₹149 Cr | ₹130 Cr | ₹124 Cr | ₹127 Cr | ₹124 Cr | ₹153 Cr | ₹119 Cr | ₹111 Cr | ₹47 Cr | ₹41 Cr |
| ₹128 | ₹113 | ₹100 | ₹99 | ₹90 | ₹74 | ₹55 | ₹50 | ₹88 | ₹79 | ₹82 | ₹72 | ₹66 | ₹60 | ₹277 | ₹340 | ₹321 | ₹302 | ₹80 | ₹72 |
| ₹128 | ₹113 | ₹100 | ₹99 | ₹90 | ₹74 | ₹55 | ₹50 | ₹44 | ₹40 | ₹41 | ₹36 | ₹33 | ₹30 | ₹28 | ₹34 | ₹32 | ₹30 | ₹8 | ₹7 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Effect of Foreign Exchange Fluctuations
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | Mar 2009 | Mar 2008 | Mar 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹78 Cr | ₹69 Cr | ₹62 Cr | ₹54 Cr | ₹91 Cr | ₹82 Cr | ₹34 Cr | ₹35 Cr | ₹33 Cr | ₹34 Cr | ₹35 Cr | ₹26 Cr | ₹21 Cr | ₹18 Cr | ₹19 Cr | ₹16 Cr | ₹19 Cr | ₹19 Cr | ₹10 Cr | ₹14 Cr |
| -₹11 Cr | -₹9 Cr | -₹7 Cr | -₹8 Cr | -₹10 Cr | -₹3 Cr | -₹83 L | -₹3 Cr | -₹4 Cr | -₹41 L | -₹2 Cr | -₹83 L | ₹3 Cr | ₹3 Cr | ₹2 Cr | -₹1 Cr | -₹2 Cr | -₹5 Cr | ₹2 Cr | ₹1 Cr |
| -₹12 Cr | ₹9 Cr | -₹10 Cr | -₹10 Cr | -₹4 Cr | ₹31 Cr | -₹4 Cr | -₹81 L | ₹47 L | -₹11 Cr | ₹71 L | ₹3 Cr | ₹70 L | -₹6 Cr | -₹3 Cr | -₹4 Cr | ₹3 Cr | -₹1 Cr | -₹5 Cr | ₹2 Cr |
| ₹55 Cr | ₹69 Cr | ₹44 Cr | ₹36 Cr | ₹76 Cr | ₹110 Cr | ₹29 Cr | ₹31 Cr | ₹30 Cr | ₹22 Cr | ₹33 Cr | ₹28 Cr | ₹25 Cr | ₹14 Cr | ₹19 Cr | ₹10 Cr | ₹20 Cr | ₹13 Cr | ₹8 Cr | ₹18 Cr |
| ₹36 Cr | ₹51 Cr | ₹28 Cr | ₹20 Cr | ₹52 Cr | ₹91 Cr | ₹18 Cr | ₹21 Cr | ₹19 Cr | ₹8 Cr | ₹21 Cr | ₹19 Cr | ₹18 Cr | ₹8 Cr | ₹13 Cr | ₹6 Cr | ₹12 Cr | ₹7 Cr | ₹6 Cr | ₹11 Cr |
| -₹21 Cr | -₹31 Cr | ₹19 Cr | -₹2 Cr | -₹36 Cr | -₹88 Cr | -₹14 Cr | -₹11 Cr | -₹8 Cr | -₹29 L | ₹1 Cr | -₹5 Cr | ₹16 Cr | ₹11 Cr | ₹4 Cr | -₹30 Cr | -₹47 Cr | ₹88 Cr | -₹9 Cr | -₹4 Cr |
| -₹14 Cr | -₹13 Cr | -₹48 Cr | -₹15 Cr | -₹17 Cr | -₹7 Cr | -₹12 Cr | -₹7 Cr | -₹9 Cr | -₹5 Cr | -₹11 Cr | -₹12 Cr | -₹14 Cr | -₹17 Cr | -₹27 Cr | ₹20 Cr | -₹8 Cr | -₹30 Cr | -₹2 Cr | -₹1 Cr |
| ₹1 Cr | ₹6 Cr | -₹1 Cr | ₹3 Cr | -₹72 L | -₹4 Cr | -₹7 Cr | ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹12 Cr | ₹2 Cr | ₹20 Cr | ₹2 Cr | -₹9 Cr | -₹4 Cr | -₹43 Cr | ₹65 Cr | -₹5 Cr | ₹6 Cr |
| ₹10 Cr | ₹4 Cr | ₹5 Cr | ₹2 Cr | ₹3 Cr | ₹7 Cr | ₹15 Cr | ₹11 Cr | ₹10 Cr | ₹22 Cr | ₹31 Cr | ₹29 Cr | ₹9 Cr | ₹7 Cr | ₹24 Cr | ₹24 Cr | ₹68 Cr | ₹3 Cr | ₹8 Cr | ₹2 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | -₹2,000 | -₹9,000 | -₹10,000 | -₹7,000 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | -₹5 L |
| ₹11 Cr | ₹10 Cr | ₹4 Cr | ₹5 Cr | ₹2 Cr | ₹3 Cr | ₹7 Cr | ₹15 Cr | ₹11 Cr | ₹25 Cr | ₹42 Cr | ₹31 Cr | ₹29 Cr | ₹9 Cr | ₹15 Cr | ₹20 Cr | ₹24 Cr | ₹68 Cr | ₹3 Cr | ₹8 Cr |
Fundamental Ratios
Consolidated
Standalone

No results found
Amrutanjan Health Care Share Price
512.65+0.00 (-0.85%)
-26.34% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 3
Bearish signals: 2 out of 9 oscillators
RSI
53.71Neutral
STOCH %K
52.09Neutral
MACD Level(12,26)
2.82Buy
Ultimate Oscillator
43.22Sell
Aroon Oscillator
74.00Buy
BOP
-0.31Sell
CCI
39.81Neutral
Williams %R
-47.91Neutral
Momentum
16.25Buy
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 6
Bearish signals: 3 out of 9 moving averages
EMA 9
512.53Buy
SMA 9
513.41Sell
EMA 21
509.57Buy
SMA 21
506.16Buy
EMA 50
508.74Buy
SMA 50
504.92Buy
EMA 200
546.63Sell
SMA 200
537.29Sell
WMA 20
511.39Buy
Pivot
Pivot
Classic
Resistance 5
577.83
Resistance 4
562.48
Resistance 3
547.13
Resistance 2
531.78
Resistance 1
524.42
Pivot
516.43
Support 1
509.07
Support 2
501.08
Support 3
485.73
Support 4
470.38
Support 5
455.03
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Amrutanjan Health Care Share Price
512.65+0.00 (-0.85%)
-26.34% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| 46.52% | 46.52% | 46.52% | 46.52% | 46.52% | 46.52% |
| 3.47% | 2.44% | 2.17% | 2.27% | 2.38% | 2.41% |
| 3.30% | 6.47% | 5.64% | 5.45% | 5.35% | 5.15% |
| 3.60% | 5.82% | 7.02% | 7.55% | 7.55% | 7.55% |
| 43.11% | 38.75% | 38.65% | 38.21% | 38.20% | 38.37% |
Bulk & block deals
Name
Dsp Mutual Fund
Pari Washington India Master Fund, Ltd.
Envision India Fund
Sundaram Mutual Fund
Nageswaramma Private Trust
Nageswaramma Private Trust
Icici Prudential Mutual Fund
Graviton Research Capital Llp
Graviton Research Capital Llp
Graviton Research Capital Llp
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 20 Aug 2026 | Sell | 25 Cr | ₹500.01 | 5 L | Bulk | 1.729469 | BSE |
| 20 Aug 2026 | Purchase | 29.17 Cr | ₹500 | 5.83 L | Bulk | 2.018225 | BSE |
| 20 Aug 2026 | Sell | 11.15 Cr | ₹523.58 | 2.13 L | Bulk | 0.736754 | NSE |
| 13 Jan 2025 | Sell | 14.95 Cr | ₹700 | 2.13 L | Bulk | 0.738483 | NSE |
| 27 Sep 2024 | Sell | 25.36 Cr | ₹745.29 | 3.40 L | Bulk | 1.17699 | BSE |
| 26 Sep 2024 | Sell | 63.29 Cr | ₹760.08 | 8.33 L | Bulk | 2.880345 | NSE |
| 26 Sep 2024 | Purchase | 49.40 Cr | ₹760 | 6.50 L | Bulk | 2.24831 | NSE |
| 30 Jun 2023 | Purchase | 14.12 Cr | ₹737.21 | 1.92 L | Bulk | 0.662522 | NSE |
| 30 Jun 2023 | Sell | 14.13 Cr | ₹737.86 | 1.92 L | Bulk | 0.662522 | NSE |
| 10 Jun 2020 | Purchase | 5.95 Cr | ₹391.16 | 1.52 L | Bulk | 0.525842 | NSE |
Insider trading & SAST
Client name
Dsp Trustee Pvt Ltd & Others
S Jeyakanth
Nageswaramma Private Trust
Nageswaramma Private Trust
Nageswaramma Pvt Trust
Nageswaramma Private Trust
Nageswaramma Private Trust
Aravind Prasad Venketasesha Sivalenka
Aravind Prasad Venketasesha Sivalenka
Goodhealth Holdings Pvt Ltd
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24 Aug 2026 | Other | Disposal | 0.73 | 2.82 | 0 | — | 2.11 L | 31 Jul 2026 | Market | 8,16,220 | SAST | 29(2) | — |
| 29 May 2025 | Designated Person | Disposal | 0.004843 | 0 | 0 | — | 1.40 K | 21 May 2025 - 28 May 2025 | Market Sale | 156 | Insider Trading | — | Equity Shares |
| 18 Oct 2024 | Promoter | Disposal | 1.18 | 4.74 | 0 | — | 3.40 L | 27 Sep 2024 | Market | 13,71,530 | SAST | 29(2) | — |
| 03 Oct 2024 | Promoter | Disposal | 1.17699 | 4.74 | 24.73 Cr | ₹726.66 | 3.40 L | 27 Sep 2024 | Market Sale | 13,71,530 | Insider Trading | — | Equity Shares |
| 01 Oct 2024 | Promoter | Disposal | 2.88 | 5.92 | 0 | — | 8.33 L | 26 Sep 2024 | Market | 17,11,805 | SAST | 29(2) | — |
| 30 Sep 2024 | Promoter | Disposal | 2.880345 | 5.92 | 61.71 Cr | ₹741.08 | 8.33 L | 26 Sep 2024 | Market Sale | 17,11,805 | Insider Trading | — | Equity Shares |
| 15 Jun 2024 | Promoter | Acquisition | 0.13 | 8.81 | 0 | — | 36.53 K | 12 Jun 2024 | Transmission | 25,44,530 | SAST | 29(2) | — |
| 08 May 2024 | Promoter | Acquisition | 0.01 | 0.01 | 0 | — | 4.42 K | 02 May 2024 | Transmission | 4,420 | SAST | 29(1) | — |
| 08 May 2024 | Promoter | Acquisition | 0.01 | 0.01 | 0 | — | 4.42 K | 02 May 2024 | Transmission | 4,420 | SAST | 29(2) | — |
| 07 Mar 2024 | Promoter | Disposal | 20.15 | 50.59 | 0 | — | 58.26 L | 29 Feb 2024 | Transfer | 1,46,25,610 | SAST | 29(2) | — |
Amrutanjan Health Care Share Price
512.65+0.00 (-0.85%)
-26.34% past 1 Year
Amrutanjan Health Care Ltd is engaged in the manufacture of a wide range of ayurvedic and allopathic products. The company's products are available in the Gulf African South East and
Corporate Actions
Date
Type
Details
Company details
Amrutanjan Health Care Share Price
512.65+0.00 (-0.85%)
-26.34% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Amrutanjan Health Care Share Price
512.65+0.00 (-0.85%)
-26.34% past 1 Year
News
1 of 20
ResultAMRUTANJAN3 Nov 2026
NULL
Amrutanjan Reports Stronger Q2 EBITDA Growth And Margin Expansion
ResultAMRUTANJAN3 Nov 2026
Amrutanjan Health Care reported Q2 EBITDA of Rs 23.60 crores, compared with Rs 16.52 crores in the corresponding quarter a year earlier, representing year-on-year growth of approximately 42.9%. EBITDA margin improved to 17.47% from 14.04% year-on-year, reflecting stronger operating profitability. Revenue and PAT figures, quarter-on-quarter comparisons, management commentary, consensus estimates, and market reaction were not provided in the available information.
Amrutanjan Healthcare Reports Stronger Second Quarter Net Profit Growth
ResultAMRUTANJAN3 Nov 2026
Amrutanjan Healthcare reported Q2 net profit of Rs 17.30 crores, compared with Rs 13.96 crores in the corresponding quarter of the previous year, representing a year-on-year increase of approximately 23.9%. Revenue, EBITDA, operating margin, net margin, quarter-on-quarter performance, and street expectations were not provided in the available information. The result indicates improved profitability during the reported quarter, although the absence of broader operating metrics limits assessment of earnings quality and business momentum.
Amrutanjan Q2 Revenue Rises To Rs 135 Crores From Rs 118 Crores
ResultAMRUTANJAN3 Nov 2026
Amrutanjan Health Care reported Q2 revenue of Rs 135 crores, up from Rs 118 crores in the corresponding period a year earlier, representing approximately 14.4 percent YoY growth. EBITDA, PAT, operating margin, net margin, QoQ revenue, analyst expectations, management commentary, and market reaction were not provided.
Amrutanjan Healthcare sees Rs 46.51 crore BSE block trade at Rs 500 per share
Block DealAMRUTANJAN20 Aug 2026
Amrutanjan Healthcare witnessed a BSE block trade valued at Rs 46.51 crore, involving about 9.30 lakh shares at Rs 500 each.
Based on the provided trade details, the transaction size indicates meaningful secondary market activity in the stock. The disclosure does not specify the buyer or seller, and no change in promoter holding or institutional ownership can be confirmed from the available text.
The reported trade price of Rs 500 per share is the key reference point for the deal. No separate information is available on a premium or discount versus the prevailing market price, and no post-trade stock reaction is provided in the input.
Amrutanjan Health Care posts lower Q1 EBITDA and margin year on year
ResultAMRUTANJAN11 Aug 2026
Amrutanjan Health Care reported Q1 EBITDA of Rs 6.20 crores, compared with Rs 8.40 crores in the same quarter last year.
EBITDA margin declined to 6.06% from 8.97% year on year, indicating weaker operating efficiency in the quarter. The provided update does not include revenue, PAT, or quarterly comparison data, so those figures are not stated. No management commentary, guidance, or market reaction was provided in the context.
Amrutanjan Health Care reports Q1 revenue rise to Rs 100.00 crores
ResultAMRUTANJAN11 Aug 2026
Amrutanjan Health Care reported Q1 revenue of Rs 100.00 crores versus Rs 94.00 crores in the same quarter last year, indicating a YoY increase of about 6.4%.
No EBITDA, PAT, margin, or QoQ figures were provided in the context, so those metrics are not included here. The update is a routine quarterly revenue disclosure for the company and does not include management guidance, consensus comparison, or stock reaction.
Amrutanjan Health Care reports lower first quarter net profit year on year
ResultAMRUTANJAN11 Aug 2026
Amrutanjan Health Care reported a standalone net profit of Rs 4.40 crores for the first quarter, compared with Rs 8.30 crores in the same period last year, indicating a year on year decline in bottom line performance.
The available update does not provide revenue, EBITDA, or margin figures, so those metrics cannot be assessed from the context. No quarterly comparison, management commentary, or market reaction is included in the input. The result update is limited to the reported PAT figure and its comparison with the prior year quarter.
Amrutanjan commissions new Telangana sanitary napkin plant with Rs 150 crore capex
Stock NewsAMRUTANJAN5 Aug 2026
Amrutanjan has commissioned a new sanitary napkin manufacturing facility in Telangana, marking a significant expansion of its personal hygiene production footprint. The company has invested Rs 150 crores in this greenfield plant, indicating a meaningful medium-scale capital expenditure aimed at strengthening its presence in the fast-growing feminine hygiene segment. By adding dedicated sanitary napkin capacity, Amrutanjan is positioned to enhance its product availability across key markets, potentially supporting revenue growth over the medium term as utilisation ramps up.
The new facility is expected to produce 70.00 crores sanitary napkins annually, providing substantial incremental manufacturing capacity that can help the company scale volumes, improve operating leverage, and better address demand in both urban and semi-urban markets. The plant is also projected to generate employment, with plans to create around 200 direct jobs and 150 indirect jobs, supporting the local Telangana economy and strengthening Amrutanjan’s on-ground execution and distribution capabilities. Over time, higher capacity and streamlined production could aid margins through efficiencies, subject to raw material trends and competitive pricing dynamics in the sanitary products space.
From an earnings and market share perspective, the commissioning of a dedicated sanitary napkin facility underscores Amrutanjan’s strategic focus on the hygiene and wellness category, which structurally benefits from rising awareness, increasing penetration, and demographic tailwinds in India. The scale of the plant suggests that the company is targeting larger volumes and broader market reach, which may incrementally improve its competitive positioning against established players. Near term, the capex outlay may weigh on free cash flows, but successful ramp-up of the Telangana facility can support top-line growth and operating scale, with potential positive implications for long-term shareholder value.
Amrutanjan Health Care Adds 44,000 New Chemists, Targets 100,000 by September FY27
Stock NewsAMRUTANJAN9 May 2026
Amrutanjan Health Care Ltd has significantly expanded its distribution network by onboarding 44,000 new chemists. The company aims to reach a total of 100,000 chemists by September FY27, enhancing its market penetration in the healthcare and consumer products segment.
This aggressive expansion is poised to boost product accessibility, potentially driving higher sales volumes and revenue growth. By widening its retail footprint, Amrutanjan could capture greater market share in pain relief and wellness categories, where distribution density is a key competitive factor. The initiative underscores the company's strategy to scale operations amid rising demand for over-the-counter health products.
No specific financial impacts such as revenue projections or capex details were disclosed in the update. The development aligns with broader efforts in the FMCG-healthcare space to strengthen offline presence amid evolving consumer preferences.
Amrutanjan Healthcar - Quaterly Results
ResultAMRUTANJAN8 May 2026
NULL
Amrutanjan Healthcar reports Profit after tax of 16.19 Crores, in the March 2026 quarter
ResultAMRUTANJAN8 May 2026
NULL
Amrutanjan Health Care Reports Strong Q4 EBITDA Growth to Rs 25.50 Crores, Margin at 17.05%
ResultAMRUTANJAN8 May 2026
Amrutanjan Health Care announced its Q4 financial results, showcasing significant improvement in profitability metrics. EBITDA for the quarter rose to Rs 25.50 crores, marking a robust year-over-year (YoY) increase from Rs 17.70 crores. This growth reflects enhanced operational efficiency and stronger topline performance in the healthcare products segment.
The EBITDA margin expanded notably to 17.05% from 13.07% in the previous year's corresponding quarter, indicating better cost management and pricing power. No details on revenue, PAT, or QoQ comparisons were provided in the update. The results highlight Amrutanjan's resilience in the consumer healthcare space amid market dynamics.
Amrutanjan Health Care Q4 FY25 Net Profit Rises 6% YoY to Rs 16.10 Crores, Revenue Up 11% to Rs 150 Crores
ResultAMRUTANJAN8 May 2026
Amrutanjan Health Care reported its Q4 FY25 earnings, showing year-on-year growth in key financial metrics. Net profit increased to Rs 16.10 crores from Rs 15.20 crores in the previous year's corresponding quarter, marking a growth of approximately 6%. Revenue for the quarter stood at Rs 150 crores, up from Rs 135 crores YoY, reflecting an 11% expansion.
The results indicate steady performance in the healthcare products segment, driven by topline growth. No details on EBITDA, margins, or quarter-on-quarter comparisons were provided in the update. Street expectations or management guidance were not mentioned.
Amrutanjan Health Care informs about product launch
Stock NewsAMRUTANJAN17 Apr 2026
NULL
Amrutanjan Healthcar - Quaterly Results
ResultAMRUTANJAN3 Feb 2026
NULL
Amrutanjan Health Care Q3 EBITDA Rises 7.7% YoY to Rs 25.20 Crores, Margin Contracts to 17.85%.
ResultAMRUTANJAN3 Feb 2026
Amrutanjan Health Care reported Q3 **EBITDA** of **Rs 25.20 Crores**, up from **Rs 23.40 Crores** YoY, reflecting a 7.7% growth. **EBITDA margin** narrowed to **17.85%** from **19.02%** YoY.
No revenue, PAT, or QoQ figures available in the provided context. Results align with the board meeting scheduled for February 3, 2026, to approve Q3 FY26 unaudited financials[3]. Prior quarters show revenue of Rs 140.23 Crores and PAT of Rs 15.18 Crores in Q4 FY25, with Dec 2024 PAT at Rs 19.25 Crores[1][4].
Amrutanjan Health Care Q3 Net Profit Up Slightly to Rs 19.50 Crores, Revenue Rises to Rs 140 Crores YoY.
ResultAMRUTANJAN3 Feb 2026
Amrutanjan Health Care reported Q3 results with net profit at Rs 19.50 crores, up from Rs 19.20 crores year-over-year (YoY). Revenue increased to Rs 140.00 crores from Rs 122.00 crores YoY, reflecting strong top-line growth of approximately 14.75%.
The results indicate steady profitability with marginal net profit growth of 1.56% YoY, supported by robust revenue expansion. No EBITDA or margin details were provided in the context. Supporting data from recent quarters shows Q4 revenue at Rs 140.23 crores with net profit of Rs 15.18 crores and net profit margin of 10.83%. Sequential trends include revenue growth of 10.32% QoQ in Q4, though net profit declined 21.14% QoQ.
Stock price stood at Rs 587.30, up 2.21% on February 3, 2026, suggesting positive market reaction post-results. No management commentary or guidance mentioned. Results align with category focus on earnings and corporate performance for AMRUTANJAN on NSE/BSE.
Amrutanjan Healthcar reports Profit after tax of 19.45 Crores, in the December 2025 quarter
ResultAMRUTANJAN3 Feb 2026
NULL
Amrutanjan Health Care informs about certificate
Stock NewsAMRUTANJAN8 Jan 2026
NULL

